A Study Comparing Insulin Peglispro With Insulin Glargine as Basal Insulin Treatment

Clinical trial NCT01894568 · COMPLETED

Trial details

NCT number: NCT01894568
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Type 2 Diabetes Mellitus

Start date: 2013-07-01
Primary completion: 2015-04-01
Enrollment: 388

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.